Abstract
| Original language | English |
|---|---|
| Article number | 1-15 |
| Number of pages | 15 |
| Journal | South Eastern European Journal of Public Health |
| Volume | XIV |
| DOIs | |
| Publication status | Published - Aug 2020 |
Access to Document
- 10.4119/seejph-3684Licence: CC BY
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: South Eastern European Journal of Public Health, Vol. XIV, 1-15, 08.2020.
Research output: Contribution to journal › (Systematic) Review article › peer-review
TY - JOUR
T1 - Risk management and prevention of antibiotics resistance
T2 - The PREVENT IT project
AU - Kaur, Kiranjeet
AU - Greco, Stefano
AU - Saroj, Sunil D.
AU - Hossain, Shaikh Shah
AU - Pradhan, Himanshu Sekhar
AU - Singh, Sanjeev K.
AU - Clerici, Francesca
AU - Sood, Meenakshi
AU - Brand, Helmut
AU - John, Preethi
AU - Schroder-Back, P.
N1 - Funding Information: Background: Globally, a significant increase in the emergence of antibiotic resistant (ABR) pathogens has rendered several groups of antibiotics ineffective for the treatment of life-threatening infections. It is an endemic in hospital settings and a major concern while handling pathogens involved in an epidemic or pandemic. ABR is a matter of great concern due to its recusant impact on public health and cost to the healthcare system, especially in developing country like India. An indiscriminate and inappropriate usage of antimicrobials, poor infrastructure and sanitation are the major factors driving the evolution of ABR in such countries. Therefore, in addition to the development of novel therapeutics and safeguarding the efficacy of existing antibiotics, there is an urgent need for a programme focussed on the education in risk management and prevention of ABR. Aim: To promote qualitative teaching activities in academia and society to visualize a future where every individual is aware of ABR and empowered with right education to address the issue. Methods: The project ‘Risk Management and Prevention of Antibiotics Resistance - PREVENT IT’, funded by the ERASMUS+ Programme of the European Union, converges academicians and non-government organizations (NGOs) to inculcate a sense of awareness towards the increase in the frequency of ABR pathogens, judicial usage of antimicrobials and the economic/health burden of ABR, in students, academicians, clinicians and population at large. Expected outcome: The project commissioned envisages a behavioural change in individuals and attempts to support policymakers by executing stable changes in the curricula of institutes of higher education, developing advanced workshop modules for the training of academicians and disseminating ABR-related information through conferences/seminars, social media campaigns and an online platform dedicated to ABR. In addition, the project aims to develop a European-Indian network for the management of risk and prevention of ABR. Funding Information: Of the various health issues faced by the world today including COVID 19, antimicrobial resistance (AMR) is a growing problem that poses a grave threat to global public health (1). The term AMR pertains to the inability of the antibiotic to treat or cure the infection caused by microorganisms. Reports from the World Health Organization (WHO), have also declared AMR being the sole factor to be responsible for approximately 10 million deaths by 2050 (2). Given the fact that AMR is not constricted by demography or geography, it needs to be addressed globally (3). The global AMR response is listed in the WHO’s core mandate, stressing the importance and priority to seek its remedy. The Global Action Plan on Antimicrobial resistance by WHO (4) and the National Action Plan on Antimicrobial Resistance NAP-AMR (5) by the Govt. of India are some of the global and local initiatives to combat the predicted adverse conditions. These action plans hinge on a multi-pronged approach that include: 1. Creating awareness through education and training 2. AMR Surveillance 3. Prevention and Control Measures, including 3a. Rational use of antibiotics 3b. Research and Innovative Practices like improved diagnostics for reduc-ing use of antibiotics 3c. Therapeutics; that minimizes use of antibiotics 4. Collaboration facilitation Though, all the approaches mentioned above are equally significant, creating awareness through education, targets the problem at the base level. As per a review conducted in 2016 by O’-Neill (6), the emphasis was laid on the urgency of creating global awareness campaign to educate the public, particularly youngsters about the ramifications of drug resistance. These initiatives have the potential to bring about behavioral change in the mind-set of the youth. It is said that developing countries, such as India, with their enormous youth population could see their economies rise, only if they invest profoundly in young people's education and health (7). An innovative project initiated to address these challenges, named Risk Management and Prevention of Antibiotics Resistance - PREVENT IT, is being undertaken in India, in alignment with the National Action Plan (NAP) and funded by the European Commission under the Erasmus+ scheme. The project comprises of seven Indian partners and four European partners. The vision of the project is a future where every individual is aware of antibiotic resistance (ABR) and empowered with the right education to address and seek remedial course of action to prevent the further development of drug resistance. It is imperative for all the key stakeholders - academicians, researchers and non-governmental organizations - to coordinate and collaborate to ensure that health systems are better prepared to prevent and tackle the AMR threat. Funding Information: acknowledge the contribution of partners from NGOs, Riga Stradins University and Catholic University of Portugal for their continuous help and support. This project has been funded with support from the European Commission. This manuscript reflects the Publisher Copyright: © 2020 Kaur et al;.
PY - 2020/8
Y1 - 2020/8
N2 - Background: Globally, a significant increase in the emergence of antibiotic resistant (ABR) path-ogens has rendered several groups of antibiotics ineffective for the treatment of life-threatening infections. It is an endemic in hospital settings and a major concern while handling pathogens involved in an epidemic or pandemic. ABR is a matter of great concern due to its recusant impact on public health and cost to the healthcare system, especially in developing country like India. An indiscriminateand inappropriate usage of antimicrobials, poor infrastructure and sanitation are the major factors driving the evolution of ABR in such countries. Therefore, in addition to the devel-opment of novel therapeuticsand safeguarding the efficacy of existing antibiotics, there is an ur-gent need for a programme focussed on the education in risk management and prevention of ABR. Aim: To promote qualitative teaching activities in academia and society to visualize a future where every individual is aware of ABR and empowered with right education to address the issue.Methods: The project ‘Risk Management and Prevention of Antibiotics Resistance -PREVENT IT’, funded by the ERASMUS+ Programme of the European Union, converges academicians and non-government organizations (NGOs) to inculcate a sense of awareness towards the increase in the frequency of ABR pathogens, judicial usage of antimicrobials and the economic/health burden of ABR, in students, academicians, clinicians and population at large. Expected outcome: The project commissioned envisages a behavioural change in individuals and attempts to support policymakers by executing stable changes in the curricula of institutes of higher education, developing advanced workshop modules for the training of academicians and disseminating ABR-related information through conferences/seminars, social media campaigns and an online platform dedicated to ABR. In addition, the project aims to develop a European-Indian network for the management of risk and prevention of ABR.
AB - Background: Globally, a significant increase in the emergence of antibiotic resistant (ABR) path-ogens has rendered several groups of antibiotics ineffective for the treatment of life-threatening infections. It is an endemic in hospital settings and a major concern while handling pathogens involved in an epidemic or pandemic. ABR is a matter of great concern due to its recusant impact on public health and cost to the healthcare system, especially in developing country like India. An indiscriminateand inappropriate usage of antimicrobials, poor infrastructure and sanitation are the major factors driving the evolution of ABR in such countries. Therefore, in addition to the devel-opment of novel therapeuticsand safeguarding the efficacy of existing antibiotics, there is an ur-gent need for a programme focussed on the education in risk management and prevention of ABR. Aim: To promote qualitative teaching activities in academia and society to visualize a future where every individual is aware of ABR and empowered with right education to address the issue.Methods: The project ‘Risk Management and Prevention of Antibiotics Resistance -PREVENT IT’, funded by the ERASMUS+ Programme of the European Union, converges academicians and non-government organizations (NGOs) to inculcate a sense of awareness towards the increase in the frequency of ABR pathogens, judicial usage of antimicrobials and the economic/health burden of ABR, in students, academicians, clinicians and population at large. Expected outcome: The project commissioned envisages a behavioural change in individuals and attempts to support policymakers by executing stable changes in the curricula of institutes of higher education, developing advanced workshop modules for the training of academicians and disseminating ABR-related information through conferences/seminars, social media campaigns and an online platform dedicated to ABR. In addition, the project aims to develop a European-Indian network for the management of risk and prevention of ABR.
U2 - 10.4119/seejph-3684
DO - 10.4119/seejph-3684
M3 - (Systematic) Review article
SN - 2197-5248
VL - XIV
JO - South Eastern European Journal of Public Health
JF - South Eastern European Journal of Public Health
M1 - 1-15
ER -